Medplast Baltic, UAB - financials and debts

Company age: 20 y. 6 mo.

Update

Medplast Baltic - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 442,406 535,666 623,932 778,938 918,984 686,029 578,219 326,590
Profit before tax 25,254 44,913 150,581 135,968 151,908 181,472 81,577 31,364
Net profit 21,397 38,896 127,537 116,439 129,377 154,002 70,012 26,399
Equity 69,694 78,590 176,105 192,544 185,951 170,688 175,480 131,291
Liabilities 123,103 157,290 197,663 207,185 190,836 54,967 72,408 51,088
Non-current assets 46,502 54,067 40,411 27,073 16,226 32,832 26,392 17,955
Current assets 145,679 181,271 332,859 372,019 359,710 191,855 219,920 161,908
Total assets 192,181 235,338 373,270 399,092 375,936 224,687 246,312 179,863
Taxes paid
STI taxes - - - - - 209,679 173,050 98,296
Social insurance contributions - - - - - 33,384 33,265 34,644
Financial indicators
Revenue change y/y -2.9% +21.1% +16.5% +24.8% +18.0% -25.3% -15.7% -43.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 11.1% 16.5% 34.2% 29.2% 34.4% 68.5% 28.4% 14.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 30.7% 49.5% 72.4% 60.5% 69.6% 90.2% 39.9% 20.1%
Profit margin Net profit margin. Shows the overall profitability of the company. 4.8% 7.3% 20.4% 14.9% 14.1% 22.4% 12.1% 8.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 5.7% 8.4% 24.1% 17.5% 16.5% 26.5% 14.1% 9.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.8 2.0 1.1 1.1 1.0 0.3 0.4 0.4
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 52,563 66,958 89,133 102,718 116,082 104,207 96,370 63,211

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Medplast Baltic - Social security debts

From To Debt, €
2025-09-07 2025-09-14 6.90
2025-08-31 2025-09-03 6.90
2025-07-17 2025-08-29 6.90
2025-06-17 2025-06-24 2845.88
2025-06-11 2025-06-16 5.16
2025-06-08 2025-06-09 5.16
2025-05-16 2025-06-04 5.16
2025-05-08 2025-05-11 2.26
2025-05-04 2025-05-07 5.16
2025-04-24 2025-04-29 5.16
2025-03-18 2025-03-25 2123.47
2023-03-16 2023-03-19 2519.85

Medplast Baltic - VMI tax arrears

From To Overdue, €
2025-10-08 2025-10-23 1.54
2025-10-02 2025-10-07 269.96
2025-09-30 2025-10-01 269.47
2025-09-26 2025-09-29 271.05
2025-09-25 2025-09-25 463.05
2025-09-19 2025-09-24 979.68
2025-07-28 2025-07-30 4377.58

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Medplast Baltic, UAB (code 300554732) is a Private Limited Liability Company engaged in wholesale of pharmaceutical and medical goods. In the latest financial year 2025, the company generated revenue of €326.6K and net profit of €26.4K, giving a profit margin of 8.1%. Performance weakened compared with prior years: revenue fell from €686.0K in 2023 to €578.2K in 2024 and then to €326.6K in 2025, while net profit declined from €154.0K to €70.0K and then to €26.4K. Even so, the company remained profitable throughout the period. At year-end 2025, total assets stood at €179.9K, equity at €131.3K and liabilities at €51.1K, indicating a solid equity position with an equity ratio of 73.0% and debt-to-equity of 0.39. Asset turnover was 1.82x, ROE was 20.1% and ROA was 14.7%. Revenue per employee was €65.3K and profit per employee was €5.3K.